Listen to article \u2022\u00a00:00 min<\/p>\n
The University of Pennsylvania<\/a> has extended the contract of its health system CEO Kevin Mahoney through June 2031.<\/p>\n Mahoney became CEO in July 2019<\/a>, and \u201conly a few months later, helped lead Penn Medicine through the COVID-19 pandemic, which changed the face of healthcare,\u201d Jonathan A. Epstein, dean of Penn\u2019s Perelman School of Medicine, said in an email Thursday evening to medical school and health system leaders.<\/p>\n \u201cSince that time, Kevin has kept Penn Medicine moving forward despite a rapidly changing healthcare landscape by expanding access points, building a sustainable talent pipeline, and advocating for safer, more supportive care environments for clinicians and staff,\u201d said Epstein, who is also a university executive vice president with responsibility for the nonprofit health system.<\/p>\n Mahoney\u2019s current contract was due to end next June. He has worked at Penn for almost 30 years.<\/p>\n After the pandemic, he launched a framework called Repair\u2013Refocus\u2013Reimagine to reduce costs and boost revenue, with the goal of getting back to 4% operating profit margins. A key role for the health system within the larger university is to financially support medical education and research.<\/p>\n Since Mahoney became CEO, Penn completed construction of the $1.6 billion Hospital of University of Pennsylvania patient tower in University City<\/a>, now called the Clifton Center for Medical Breakthroughs. <\/a><\/p>\n In West Philadelphia<\/a>, Mahoney led a consortium that maintained healthcare services<\/a> at the former Mercy Philadelphia Hospital, which Trinity Health Mid-Atlantic had decided to close.<\/p>\n Penn acquired Doylestown Health last year, increasing the number of hospitals Penn owns to seven.<\/p>\n Mahoney also has continued the system\u2019s outpatient push, with a $270 million site in Montgomeryville<\/a> scheduled to open late next year. <\/p>\n